Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Atara Biotherapeutics | 969 | 2022 | |||||||||
Gevo | 196 | 2023q3 | |||||||||
Guardion Health Sciences | 491 | 2021 | |||||||||
Nektar Therapeutics | 95 | 2023q3 | |||||||||
Danimer Scientific | 35 | 2024q2 | |||||||||
Nurix Therapeutics | 963 | 2024q3 | |||||||||
Vuzix | 57 | 2023q3 | |||||||||
Qudian | 465 | 2024q1 | |||||||||
Blueprint Medicines | 5,358 | 2022 | |||||||||
Legend Biotech | 8,034 | 2023q2 | |||||||||
REGENXBIO | 534 | 2023q3 | |||||||||
FibroGen | 33 | 2023q2 | |||||||||
Pacific Biosciences of Ca... | 568 | 2022 | |||||||||
Novacyt | 39 | 2023 | |||||||||
Co-Diagnostics | 36 | 2023q3 | |||||||||
Medical Properties Trust | 2,707 | 2024q2 | |||||||||
ΠΠ Π Π£Π‘Π‘-ΠΠΠΠΠ‘Π’ | 60 | 2024q2 | |||||||||
American Well | 339 | 2023q3 | |||||||||
Ballard Power Systems | 1,359 | 2023q1 | |||||||||
Prothena | 1,362 | 2022 |